Literature DB >> 27339271

CXCR4+ CD45- Cells are Niche Forming for Osteoclastogenesis via the SDF-1, CXCL7, and CX3CL1 Signaling Pathways in Bone Marrow.

Yoh Goto1,2, Mineyoshi Aoyama2,3, Takeo Sekiya1,2, Hiroki Kakita2,4, Yuko Waguri-Nagaya5, Ken Miyazawa1, Kiyofumi Asai2, Shigemi Goto1.   

Abstract

Bone homeostasis comprises the balance between bone-forming osteoblasts and bone-resorbing osteoclasts (OCs), with an acceleration of osteoclastic bone resorption leading to osteoporosis. OCs can be generated from bone marrow cells (BMCs) under the tightly regulated local bone environment. However, it remained difficult to identify the critical cells responsible for providing an osteoclastogenesis niche. In this study, we used a fluorescence-activated cell sorting technique to determine the cell populations important for forming an appropriate microenvironment for osteoclastogenesis and to verify the associated interactions between osteoclast precursor cells and non-OCs. We isolated and removed a small cell population specific for osteoclastogenesis (CXCR4+ CD45- ) from mouse BMCs and cultured the remaining cells with receptor activator of nuclear factor-kappa B ligand (RANKL) and macrophage-colony stimulating factor. The resulting cultures showed significantly less large osteoclast formation. Quantitative RT-PCR analysis revealed that these CXCR4+ CD45- cells expressed low levels of RANK and RANKL, but high levels of critical chemokines including stromal cell derived factor 1 (SDF-1), chemokine (C-X-C motif) ligand 7 (CXCL7), and chemokine (C-X3-C motif) ligand 1 (CX3CL1). Furthermore, an SDF-1-specific antibody strongly suppressed OC formation in RAW264.7 cells and antibodies against SDF-1, CXCL7, and CX3CL1 suppressed OC formation in BMCs. These results suggest that isolated CXCR4+ CD45- cells support an appropriate microenvironment for osteoclastogenesis with a direct effect on the cells expressing SDF-1, CXCL7, and CX3CL1 receptors. The regulation of CXCR4+ CD45- cell function might therefore inform therapeutic strategies for diseases involving loss of bone homeostasis. Stem Cells 2016;34:2733-2743.
© 2016 AlphaMed Press.

Entities:  

Keywords:  CXCR4+CD45− cells; Microenvironment; Osteoclastogenesis; SDF-1; SDF-1/CXCR4 axis

Mesh:

Substances:

Year:  2016        PMID: 27339271     DOI: 10.1002/stem.2440

Source DB:  PubMed          Journal:  Stem Cells        ISSN: 1066-5099            Impact factor:   6.277


  10 in total

1.  Elevated Expression of Macrophage Migration Inhibitory Factor Promotes Inflammatory Bone Resorption Induced in a Mouse Model of Periradicular Periodontitis.

Authors:  Mohammed Howait; Abdullah Albassam; Chiaki Yamada; Hajime Sasaki; Laila Bahammam; Mariane Maffei Azuma; Luciano Tavares Angelo Cintra; Abhay R Satoskar; Satoru Yamada; Robert White; Toshihisa Kawai; Alexandru Movila
Journal:  J Immunol       Date:  2019-02-08       Impact factor: 5.422

2.  Monocyte Chemotactic Proteins Mediate the Effects of Hyperglycemia in Chondrocytes: In Vitro Studies.

Authors:  Adam Quincey; Subburaman Mohan; Bouchra Edderkaoui
Journal:  Life (Basel)       Date:  2022-06-03

3.  Host-Derived Matrix Metalloproteinase-13 Activity Promotes Multiple Myeloma-Induced Osteolysis and Reduces Overall Survival.

Authors:  Chen Hao Lo; Gemma Shay; Jeremy J McGuire; Tao Li; Kenneth H Shain; Jun Yong Choi; Rita Fuerst; William R Roush; Anna M Knapinska; Gregg B Fields; Conor C Lynch
Journal:  Cancer Res       Date:  2021-02-01       Impact factor: 12.701

Review 4.  Potential Role of Chemokines in Fracture Repair.

Authors:  Bouchra Edderkaoui
Journal:  Front Endocrinol (Lausanne)       Date:  2017-03-02       Impact factor: 5.555

Review 5.  Chemokines in Physiological and Pathological Bone Remodeling.

Authors:  Laura J Brylka; Thorsten Schinke
Journal:  Front Immunol       Date:  2019-09-13       Impact factor: 7.561

Review 6.  Stromal cell-derived factor-1 as a potential therapeutic target for osteoarthritis and rheumatoid arthritis.

Authors:  Robert Bragg; William Gilbert; Ahmed M Elmansi; Carlos M Isales; Mark W Hamrick; William D Hill; Sadanand Fulzele
Journal:  Ther Adv Chronic Dis       Date:  2019-10-24       Impact factor: 5.091

7.  Dissecting the phenotypic and functional heterogeneity of mouse inflammatory osteoclasts by the expression of Cx3cr1.

Authors:  Maria-Bernadette Madel; Lidia Ibáñez; Thomas Ciucci; Julia Halper; Matthieu Rouleau; Antoine Boutin; Christophe Hue; Isabelle Duroux-Richard; Florence Apparailly; Henri-Jean Garchon; Abdelilah Wakkach; Claudine Blin-Wakkach
Journal:  Elife       Date:  2020-05-13       Impact factor: 8.140

8.  Cxcl9l and Cxcr3.2 regulate recruitment of osteoclast progenitors to bone matrix in a medaka osteoporosis model.

Authors:  Quang Tien Phan; Wen Hui Tan; Ranran Liu; Sudha Sundaram; Anita Buettner; Susanne Kneitz; Benedict Cheong; Himanshu Vyas; Sinnakaruppan Mathavan; Manfred Schartl; Christoph Winkler
Journal:  Proc Natl Acad Sci U S A       Date:  2020-07-27       Impact factor: 11.205

Review 9.  Osteoclasts and Microgravity.

Authors:  John Kelly Smith
Journal:  Life (Basel)       Date:  2020-09-16

Review 10.  Role of CX3CL1/CX3CR1 Signaling Axis Activity in Osteoporosis.

Authors:  Piotr Wojdasiewicz; Pawel Turczyn; Barbara Dobies-Krzesniak; Justyna Frasunska; Beata Tarnacka
Journal:  Mediators Inflamm       Date:  2019-11-12       Impact factor: 4.711

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.